Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2305-36-4 | MDL No. : | MFCD00047853 |
Formula : | C8H9NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RPGKFFKUTVJVPY-UHFFFAOYSA-N |
M.W : | 151.16 | Pubchem ID : | 75316 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 42.77 |
TPSA : | 63.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.33 cm/s |
Log Po/w (iLOGP) : | 0.66 |
Log Po/w (XLOGP3) : | 2.66 |
Log Po/w (WLOGP) : | 1.28 |
Log Po/w (MLOGP) : | 0.21 |
Log Po/w (SILICOS-IT) : | 0.95 |
Consensus Log Po/w : | 1.15 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.79 |
Solubility : | 0.245 mg/ml ; 0.00162 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.64 |
Solubility : | 0.0345 mg/ml ; 0.000228 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.78 |
Solubility : | 2.5 mg/ml ; 0.0166 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | at 140℃; | General procedure: To a three necked flask, substituted anthranilic acid (1 meq.) was added in excess of formamide (6 meq). The reaction mixture was then heated at 140 °C for 4-6 h. The reaction was monitored with thin layer chromatography and upon completion; ice was added to the reaction mixture. The resultant solid was filtered, washed with water, dissolved in ethyl acetate, dried over MgSO4 and concentrated to obtain the pure desired product. Where product did not precipitate on addition of ice, the reaction mixture was extracted with ethyl acetate, dried over MgSO4 and concentrated to obtain the desired quinazolin-4(3H)-one derivatives 1-9, 11-15, 17-21 and 23-25.The amino derivatives 10, 16 and 22 were prepared using the following general procedure:To a reaction flask, substituted nitroquinazolin-4(3H)-one derivative (0.3 g, 1.56 mmol) was added followed by addition of 6 mL ethyl acetate and SnCl2*2H2O (2.12 g, 9.42 mmol), then reaction mixture was refluxed for 8 h. The reaction mixture was cooled to room temperature and quenched with saturated sodium bicarbonate solution, followed by repeated extraction with ethyl acetate (3 .x. 50 mL). The organic layers were combined, dried over anhydrous MgSO4 and concentrated to obtain the desired amino substituted quinazolin-4(3H)-one derivatives 10, 16 and 22.The substituted anthranilic acid (1 g) was dissolved in excess acetic anhydride (10 mL) and the resulting reaction mixture was stirred at room temperature for 4-7 h. The reaction was monitored for completion using thin layer chromatography. The solvent was evaporated under vacuum and the resultant residue was stirred with ammonia solution for 7 h. Upon completion, the reaction mixture was extracted with ethyl acetate (3 .x. 10 mL), the organic extracts were combined, dried over MgSO4 and evaporated to obtain compounds 26-30, 31a and 32. The 2-methyl-8-nitroquinazolin-4(3H)-one intermediate (31a) was reduced to compound 31 using the same procedure as reported in Scheme 1 for the synthesis of compounds 10, 16 and 22. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With palladium 10% on activated carbon; hydrogen In ethanol at 20℃; | Toasolutionof2-nitro-4-methylbenzoicacid(500mg,2.76mmol)inEtOH(5.50mL) was added 10percent palladium on charcoal (8percent w/w). The reaction mixture wassequentiallyevacuatedandpurgedwithhydrogenthreetimesthenstirredunderhydrogenat approximately atmospheric pressure and room temperature. The reaction wasmonitored by TLC and upon completion the catalyst was filtered off through a pad ofCeliteTM.Thesolventwasremovedinvacuotogive2-amino-4-methylbenzamide(416mg,2.75mmol,quant.)asawhiteamorphoussolid;mp181–183°C,lit.177–179°C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59% | With tert.-butyl lithium In hydrogenchloride; diethyl ether; water; pentane | a. 2-Amino-4-methylbenzoic acid To a cold (-78° C.) stirred solution of 2-bromo-5-methylaniline (10.0 g, 53.7 mM) in anhydrous ethyl ether (500 mL) under a nitrogen atmosphere was added t-butyllithium (127 mL of 1.7M solution, 214.8 mM) in pentane over a 15 min period during which time the temperature of the reaction was not allowed to exceed -65° C. After stirring at -78° C. for an additional 1.5 hr, the reaction mixture was quenched with an excess of crushed Dry Ice (solid CO2). After the Dry Ice had evaporated, water was added to the reaction mixture and the organic layer was separated and discarded. The aqueous layer was acidified with iN hydrochloric acid and then extracted with two portions of ethyl acetate. The combined extracts were dried (MgSO4), filtered and concentrated to provide the title amino acid (4.8 g, 59percent) as a tan crystalline solid; MS(CI): 152 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.12 g | at 20 - 110℃; for 10 h; | Aniline (0.18 g, 2 mmol) was added into a solution of 2-acetylamino-4-methylbenzoic acid (0.19 g, 1 mmol) in toluene(10 mL) at room temperature. The mixture was stirred and refluxed for 10 h at 110°C. The solvent was evaporated under reduced pressure. The mixture was separated by column chromatography to give 2-amino-4-methylbenzoic acid (3, 0.10 g)and N-acetylaniline (4, 0.12 g). 2-Amino-4-methylbenzoic acid (3)16: Mp: 188.2–189.6°C.1H NMR (400 MHz, CDCl3) δ 7.81(d, J = 8.0Hz), 6.51–6.48(m,2H), 2.28(s, 3H). Its 1H NMR data and melting point were consistent with those of standard sample.N-acetylaniline (4)17: Mp: 117.8–118.8°C. 1H NMR(400 MHz, CDCl3) δ 7.65 (br, 1H, NH), 7.50(d, 2H, J =8.0Hz), 7.30(t, 2H, J = 8.0Hz), 7.09(t, 1H, J = 7.4Hz), 2.15(s,3H). Its 1H NMR data and melting point were consistent with those of standard sample. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | Stage #1: at 0℃; for 16 h; Reflux Stage #2: With sodium hydrogencarbonate In water |
Concentrated sulphuric acid (1 mL) was added to a solution of 2-amino-4-methyl-benzoic acid (1.0 g, 6.62 mmol) in dry methanol (10 mL) at 0° C., and then heated at reflux for 16 hr. The mixture was cooled to room temperature and concentrated in vacuo. The crude compound was diluted with water (25 mL) and basified with sodium bicarbonate (10 mL). The aqueous layer was extracted with ethyl acetate (2*50 mL) and the combined organic layers were washed with water (50 mL), brine (50 mL) and dried over sodium sulfate. The organic layer was concentrated under reduced pressure affording 2-amino-4-methyl-benzoic acid methyl ester (900 mg, 82percent) as yellow liquid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | Stage #1: With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide for 3 h; Inert atmosphere Stage #2: With ammonium hydroxide In water; N,N-dimethyl-formamide for 16 h; |
Compound 22 (3.00 g, 19.8 mmol) in dry DMF (100 mL) under Ar was treated with EDC.HCl (4.17 g, 21.8 mmol) and HOBt (3.33 g, 21.8 mmol) for 3 h, after which aq. NH3 (35percent, 20 mL) was added and the mixture was stirred for 16 h. The evaporation residue, in EtOAc, was washed twice with water and with brine. Drying and evaporation gave 25 (2.04 g, 69percent) as an off-white solid: mp 151-153 °C (lit. [62] mp 148 °C); 1H NMR ((CD3)2SO) δ 2.22 (3 H, s, Me), 6.35 (1 H, dd, J = 8.0, 1.2, 5-H), 6.52 (1 H, d, J = 0.5 Hz, 3-H), 6.57 (2 H, s, NH2), 6.95 (1 H, brs, CONHH), 7.48 (1 H, d, J = 8.0 Hz, 6-H), 7.65 (1 H, brs, CONHH); 13C NMR ((CD3)2SO) (HSQC/HMBC) δ 21.03 (Me), 111.14 (1-C), 115.61 (5-C), 116.44 (3-C), 128.77 (6-C), 141.55 (2-C), 150.31 (4-C), 171.19 (C=O). |
64% | With N-hydroxybenzotriazole ammonium salt; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 1 h; | To a stirred solution of 2-amino-4-methyl-benzoic acid (300 mg, 1.99 mmol) in THF (6 mL),EDC.HCl (569 mg, 2.98 mmol), HOBt·NH3 (447 mg, 2.98 mmol) and DIPEA (1.06 mL, 5.96mmol) were added at RT and stirred for 1 h (TLC indicated complete consumption of startingmaterial). The reaction mixture was diluted with water (30 mL), extracted with EtOAc (3 x25 mL). The combined organic extracts were dried over Na2S04, concentrated under reducedpressure to give the crude compound which was purified by flash column chromatography(100-200 silica gel, 5 g, 50percent EtOAc-Hexane) to afford 2-amino-4-methyl-benzamide (190mg, 64percent) as a white solid 1H NMR [300 MHz, DMSO-d6]: J 7.62 (brs, 1H), 7.42 (d, J = 8.1 Hz, 1H), 6.93 (brs, 1H),6.54-6.46 (m, 3H), 6.30- 6.27 (m, 1H), 2.15 (s, 3H). |
60% | With ammonia; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In methanol; N,N-dimethyl-formamide at 20℃; for 24 h; Inert atmosphere | Accordingtoaliteratureprocedure,3toasolutionof2-amino-3-methylbenzoicacid(151mg,1.00mmol,1.0eq)indegassedDMF(2.00mL)wereaddedHOBt(162mg,1.20mmol,1.2eq.),EDCI.HCl(230mg,1.20mmol,1.2eq.),N,N-diisopropylethylamine(350μL,2.00mmol,2.0eq),and7MNH3/MeOH(429μL,1.50mmol,1.5eq.).Thesolutionwasstirredatroomtemperaturefor24hoursthenpouredoverwaterandtheaqueouslayerextractedwithEtOAc(320mL),thecombinedorganiclayerswashedwithbrine(25mL),driedwithNa2SO4andconcentratedinvacuo.TheresiduewaspurifiedbyFCC(gradient50percentEtOAc/hexanes to 80percent EtOAc/hexanes) to give 2-amino-3-methylbenzamide (90.0 mg,0.599mmol,60percent)asawhiteamorphoussolid;mp:144–146°C,lit.144–145°C. |
[ 50419-58-4 ]
2-Amino-3,4-dimethylbenzoic acid
Similarity: 0.96
[ 14438-32-5 ]
2-Amino-3,5-dimethylbenzoic acid
Similarity: 0.96
[ 6946-22-1 ]
3-Aminophthalic acid hydrochloride
Similarity: 0.96
[ 50419-58-4 ]
2-Amino-3,4-dimethylbenzoic acid
Similarity: 0.96
[ 14438-32-5 ]
2-Amino-3,5-dimethylbenzoic acid
Similarity: 0.96
[ 6946-22-1 ]
3-Aminophthalic acid hydrochloride
Similarity: 0.96
[ 50419-58-4 ]
2-Amino-3,4-dimethylbenzoic acid
Similarity: 0.96
[ 14438-32-5 ]
2-Amino-3,5-dimethylbenzoic acid
Similarity: 0.96
[ 6946-22-1 ]
3-Aminophthalic acid hydrochloride
Similarity: 0.96